查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968607

抗菌素抗药性监测市场分析及预测（至2035年）：类型、产品类型、服务、技术、组件、应用、最终用户、解决方案和部署类型

Antimicrobial Resistance Surveillance Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Solutions, Deployment
出版日期: | 出版商: Global Insight Services | 英文 301 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计抗菌素抗药性监测市场将从2024年的95亿美元成长到2034年的153亿美元，复合年增长率约为4.9%。抗菌素抗药性监测市场涵盖用于监测和分析病原体抗药性模式的系统和调查方法。该市场包括数据收集、实验室检测和报告工具，这些工具对于公共卫生和药物策略至关重要。抗菌素抗药性的日益严重推动了对先进监测技术的需求，这些技术能够实现及时干预和政策制定。推动该市场发展的动力来自于全球在诊断工具和数据分析方面的合作与创新，以有效应对抗药性趋势。

由于迫切需要对抗抗药性病原体，抗菌药物抗药性（AMR）监测市场正经历强劲成长。诊断设备领域是推动这一成长的主要动力，其中快速诊断测试和次世代定序技术发挥关键作用。这些技术能够快速识别抗药性菌株，这对制定有效的治疗策略至关重要。软体和服务领域也紧随其后，这主要得益于数据分析平台和云端监测系统的日益普及。这些工具能够实现即时数据共用和预测分析，从而加强全球监测工作。在诊断设备细分领域，就地检验设备凭藉其便利性和快速性，在各种医疗环境中脱颖而出，成为表现最佳的产品。检查室诊断设备凭藉其准确性和全面的检测能力，成为成长第二快的细分领域。抗菌药物抗药性（AMR）的日益普遍以及全球协调应对的必要性凸显了这些技术进步的重要性，并为这一重要市场的相关人员提供了盈利的机会。

市场区隔
按类型 病原体特异性监测、药物特异性监测、检查室监测、以地区为基础监测、医院监测、兽医监测、环境监测
产品 软体、资料库、试剂、设备、耗材、试剂盒、检测方法
服务 资料管理、咨询、培训与教育、检验服务、外包服务
科技 分子诊断、免疫检测、微生物培养、质谱分析、次世代定序、聚合酵素链锁反应（PCR）
成分 资料收集工具、资料分析工具和报告工具
应用领域 临床诊断、药物发现与开发、公共卫生监测、流行病学研究
最终用户 医院/诊所、诊断检查室、製药公司、研究机构、政府机构、兽医诊所
解决方案 整合监控系统、独立解决方案、云端解决方案、本地部署解决方案
实施表格 云端、本地部署、混合部署

市场概况：

抗菌药物抗药性监测市场正经历动态变化，市场占有率、定价和新产品推出均呈现显着发展趋势。该市场以创新监测解决方案为特征，旨在满足日益增长的抗菌药物抗药性监测需求。主要企业正策略性地推出先进产品并强化产品系列，以满足不断变化的消费者需求。价格竞争日益激烈，各企业纷纷利用成本效益策略取得竞争优势。抗菌药物抗药性的日益普遍导致对强大监测系统的需求不断增长，从而推动了市场成长。竞争格局的特征是主要企业之间的激烈竞争，尤其註重技术创新和策略合作。监管影响至关重要，严格的指导方针塑造市场动态并确保合规性。北美和欧洲凭藉先进的医疗保健基础设施和支援性的法规结构处于领先地位。亚太地区由于医疗保健投资的增加和宣传活动的加强，正崛起为一个充满潜力的市场。分子诊断技术和即时数据分析的进步预计将推动显着成长，预示着该市场前景光明。

主要趋势和驱动因素：

由于人们日益认识到抗菌素抗药性（AMR）是全球健康威胁，AMR监测市场正经历强劲成长。关键趋势包括整合先进的数据分析和人工智慧技术以增强监测能力。这项技术进步能够更精确地追踪抗药性模式，有助于及时采取干预措施。各国政府和国际组织都意识到合作的重要性，正在加大对AMR监测基础设施的投资。不断扩大的公私合营正在促进创新和资源共用，进一步加速市场发展。此外，多重抗药性感染疾病的日益普遍也推动了对综合监测解决方案的需求。新兴经济体医疗基础设施的扩张也对市场产生影响，因为AMR控制已成为这些国家的优先事项。对于提供扩充性且经济高效的监测技术的公司而言，存在着众多机会。随着全球医疗政策不断强调AMR控制的重要性，由于医疗需求快速成长的地区蕴藏着巨大的潜力，预计该市场将持续成长。

限制与挑战：

抗生素抗药性监测市场面临许多重大限制和挑战。其中一项主要挑战是实施先进监测系统高成本，这阻碍了其在低收入国家和小规模医疗机构的广泛应用。许多机构仍依赖过时的方法，导致数据不一致，抗药性模式监测不足。此外，人们普遍缺乏对抗生素抗药性监测重要性的认识和教育，导致其价值被低估。一些地区政府资金和支持不足，进一步阻碍了市场扩张。另外，抗药性机制的复杂性需要专业知识，这类知识往往短缺，使得数据分析和解读困难重重。不同平台和地区间的资料共用和整合也面临挑战，阻碍了全面的监测活动。此外，诸如资料收集和传输的及时性等后勤问题，也可能导致延误，降低抗药性追踪的有效性。所有这些因素共同阻碍了抗生素抗药性监测市场的成长和有效性。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 病原体特异性监测
    • 药物特异性监测
    • 检查室监测
    • 以地区为基础监测
    • 医院监测
    • 兽医监测
    • 环境监测
  • 市场规模及预测：依产品划分
    • 软体
    • 资料库
    • 试剂
    • 装置
    • 消耗品
    • 成套工具
    • 侦测
  • 市场规模及预测：依服务划分
    • 资料管理
    • 咨询
    • 培训和教育
    • 检查室服务
    • 外包服务
  • 市场规模及预测：依技术划分
    • 分子诊断
    • 免疫检测
    • 微生物培养
    • 质谱分析
    • 次世代定序
    • 聚合酵素链锁反应（PCR）
  • 市场规模及预测：依组件划分
    • 资料收集工具
    • 数据分析工具
    • 报告工具
  • 市场规模及预测：依应用领域划分
    • 临床诊断
    • 药物发现与开发
    • 公共卫生监测
    • 流行病学研究
  • 市场规模及预测：依最终用户划分
    • 医院和诊所
    • 诊断检查室
    • 製药公司
    • 研究所
    • 政府机构
    • 兽医诊所
  • 市场规模及预测：按解决方案划分
    • 整合监测系统
    • 独立解决方案
    • 基于云端的解决方案
    • 本地部署解决方案
  • 市场规模及预测：依发展状况
    • 云
    • 本地部署
    • 杂交种

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • bioMerieux
  • Thermo Fisher Scientific
  • Luminex Corporation
  • Alere Inc
  • OpGen
  • Accelerate Diagnostics
  • Meridian Bioscience
  • T2 Biosystems
  • Mobidiag
  • Becton Dickinson
  • Roche Diagnostics
  • Siemens Healthineers
  • Bruker Corporation
  • Qiagen
  • Abbott Laboratories

第九章：关于我们

简介目录
Product Code: GIS33633

Antimicrobial Resistance Surveillance Market is anticipated to expand from $9.5 billion in 2024 to $15.3 billion by 2034, growing at a CAGR of approximately 4.9%. The Antimicrobial Resistance Surveillance Market encompasses systems and methodologies for monitoring and analyzing resistance patterns in pathogens. This market includes data collection, laboratory testing, and reporting tools essential for public health and pharmaceutical strategies. With rising antimicrobial resistance, demand is increasing for advanced surveillance technologies that enable timely interventions and policy-making. The market is driven by the need for global collaboration and innovation in diagnostic tools and data analytics to effectively combat resistance trends.

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth, propelled by the urgent need to combat antibiotic-resistant pathogens. The diagnostic devices segment leads in performance, with rapid diagnostic tests and next-generation sequencing technologies playing pivotal roles. These technologies enable swift identification of resistant strains, crucial for effective treatment strategies. The software and services segment follows closely, driven by the increasing adoption of data analytics platforms and cloud-based surveillance systems. These tools facilitate real-time data sharing and predictive analytics, enhancing global surveillance efforts. Within the diagnostic devices sub-segment, point-of-care testing devices are emerging as top performers, offering convenience and speed in diverse healthcare settings. Laboratory-based diagnostic devices are anticipated as the second highest-performing sub-segment, given their accuracy and comprehensive testing capabilities. The rising prevalence of AMR and the need for coordinated global responses underscore the importance of these advancements, presenting lucrative opportunities for stakeholders in this critical market.

Market Segmentation
TypePathogen-specific Surveillance, Drug-specific Surveillance, Laboratory-based Surveillance, Community-based Surveillance, Hospital-based Surveillance, Veterinary Surveillance, Environmental Surveillance
ProductSoftware, Databases, Reagents, Instruments, Consumables, Kits, Assays
ServicesData Management, Consulting, Training and Education, Laboratory Services, Outsourcing Services
TechnologyMolecular Diagnostics, Immunoassays, Microbial Culture, Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction (PCR)
ComponentData Collection Tools, Data Analysis Tools, Reporting Tools
ApplicationClinical Diagnostics, Drug Discovery and Development, Public Health Surveillance, Epidemiological Studies
End UserHospitals and Clinics, Diagnostic Laboratories, Pharmaceutical Companies, Research Institutes, Government Agencies, Veterinary Clinics
SolutionsIntegrated Surveillance Systems, Standalone Solutions, Cloud-based Solutions, On-premise Solutions
DeploymentCloud, On-Premises, Hybrid

Market Snapshot:

Antimicrobial Resistance Surveillance Market is witnessing a dynamic shift with significant strides in market share, pricing, and new product launches. The market is characterized by innovative surveillance solutions that cater to the burgeoning demand for effective antimicrobial resistance monitoring. Key players are strategically launching advanced products, enhancing their portfolios to meet evolving consumer needs. The pricing landscape is competitive, with companies leveraging cost-effective strategies to gain a competitive edge. The market's growth is underpinned by the increasing prevalence of antimicrobial resistance, driving the need for robust surveillance systems. The competitive landscape is marked by intense rivalry among leading firms, with a strong emphasis on technological innovation and strategic collaborations. Regulatory influences play a pivotal role, with stringent guidelines shaping market dynamics and ensuring compliance. North America and Europe are at the forefront, driven by sophisticated healthcare infrastructures and supportive regulatory frameworks. The Asia-Pacific region is emerging as a lucrative market, propelled by rising healthcare investments and awareness initiatives. The market's future is promising, with advancements in molecular diagnostics and real-time data analytics poised to drive substantial growth.

Geographical Overview:

The Antimicrobial Resistance (AMR) Surveillance Market is witnessing significant expansion across diverse regions, each presenting unique growth opportunities. North America remains at the forefront, propelled by robust healthcare infrastructure and increased governmental initiatives to combat AMR. The region's focus on advanced technologies and data integration further accelerates market development. Europe is closely following, benefitting from strong regulatory frameworks and collaborative efforts among nations to address AMR challenges. In Asia Pacific, the market is experiencing rapid growth, driven by rising healthcare investments and the increasing burden of AMR. Countries like India and China are emerging as pivotal players, with substantial investments in surveillance systems and public health initiatives. Latin America and the Middle East & Africa are also witnessing growing potential. In Latin America, increased awareness and healthcare funding are fostering market expansion, while the Middle East & Africa are focusing on strengthening health systems to address AMR effectively.

Key Trends and Drivers:

The Antimicrobial Resistance (AMR) Surveillance Market is experiencing robust growth due to heightened awareness of AMR's global health threat. Key trends include the integration of advanced data analytics and artificial intelligence to enhance surveillance capabilities. This technological evolution is enabling more precise tracking of resistance patterns and facilitating timely interventions. Governments and international organizations are increasingly investing in AMR surveillance infrastructure, recognizing the critical need for coordinated efforts. The rise of public-private partnerships is fostering innovation and resource sharing, further propelling market development. Additionally, the growing prevalence of multi-drug resistant infections is driving demand for comprehensive surveillance solutions. The market is also influenced by the expansion of healthcare infrastructure in emerging economies, which are prioritizing AMR initiatives. Opportunities abound for companies offering scalable and cost-effective surveillance technologies. As global health policies continue to emphasize AMR mitigation, the market is poised for sustained growth, with significant potential in regions with burgeoning healthcare needs.

Restraints and Challenges:

The Antimicrobial Resistance Surveillance Market encounters several significant restraints and challenges. A primary challenge is the high cost of implementing sophisticated surveillance systems, which hampers adoption in low-income countries and smaller healthcare facilities. Many institutions still rely on outdated methods, leading to inconsistent data and inadequate monitoring of resistance patterns. Moreover, there is a pervasive lack of awareness and education about the importance of antimicrobial resistance surveillance, which diminishes its perceived value. In several regions, insufficient government funding and support further inhibit market expansion. Additionally, the complexity of resistance mechanisms necessitates specialized expertise, which is often scarce, complicating data analysis and interpretation. The market also faces challenges related to data sharing and integration across different platforms and regions, which restricts comprehensive surveillance efforts. Furthermore, logistical issues, such as timely data collection and transmission, can cause delays, reducing the efficacy of resistance tracking. These factors collectively impede the growth and effectiveness of the antimicrobial resistance surveillance market.

Key Players:

bioMerieux, Thermo Fisher Scientific, Luminex Corporation, Alere Inc, OpGen, Accelerate Diagnostics, Meridian Bioscience, T2 Biosystems, Mobidiag, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, Bruker Corporation, Qiagen, Abbott Laboratories

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Solutions
  • 2.9 Key Market Highlights by Deployment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Pathogen-specific Surveillance
    • 4.1.2 Drug-specific Surveillance
    • 4.1.3 Laboratory-based Surveillance
    • 4.1.4 Community-based Surveillance
    • 4.1.5 Hospital-based Surveillance
    • 4.1.6 Veterinary Surveillance
    • 4.1.7 Environmental Surveillance
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Databases
    • 4.2.3 Reagents
    • 4.2.4 Instruments
    • 4.2.5 Consumables
    • 4.2.6 Kits
    • 4.2.7 Assays
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Management
    • 4.3.2 Consulting
    • 4.3.3 Training and Education
    • 4.3.4 Laboratory Services
    • 4.3.5 Outsourcing Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassays
    • 4.4.3 Microbial Culture
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Next-Generation Sequencing
    • 4.4.6 Polymerase Chain Reaction (PCR)
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Data Collection Tools
    • 4.5.2 Data Analysis Tools
    • 4.5.3 Reporting Tools
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnostics
    • 4.6.2 Drug Discovery and Development
    • 4.6.3 Public Health Surveillance
    • 4.6.4 Epidemiological Studies
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals and Clinics
    • 4.7.2 Diagnostic Laboratories
    • 4.7.3 Pharmaceutical Companies
    • 4.7.4 Research Institutes
    • 4.7.5 Government Agencies
    • 4.7.6 Veterinary Clinics
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 Integrated Surveillance Systems
    • 4.8.2 Standalone Solutions
    • 4.8.3 Cloud-based Solutions
    • 4.8.4 On-premise Solutions
  • 4.9 Market Size & Forecast by Deployment (2020-2035)
    • 4.9.1 Cloud
    • 4.9.2 On-Premises
    • 4.9.3 Hybrid

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Solutions
      • 5.2.1.9 Deployment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Solutions
      • 5.2.2.9 Deployment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Solutions
      • 5.2.3.9 Deployment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Solutions
      • 5.3.1.9 Deployment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Solutions
      • 5.3.2.9 Deployment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Solutions
      • 5.3.3.9 Deployment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Solutions
      • 5.4.1.9 Deployment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Solutions
      • 5.4.2.9 Deployment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Solutions
      • 5.4.3.9 Deployment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Solutions
      • 5.4.4.9 Deployment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Solutions
      • 5.4.5.9 Deployment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Solutions
      • 5.4.6.9 Deployment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Solutions
      • 5.4.7.9 Deployment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Solutions
      • 5.5.1.9 Deployment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Solutions
      • 5.5.2.9 Deployment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Solutions
      • 5.5.3.9 Deployment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Solutions
      • 5.5.4.9 Deployment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Solutions
      • 5.5.5.9 Deployment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Solutions
      • 5.5.6.9 Deployment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Solutions
      • 5.6.1.9 Deployment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Solutions
      • 5.6.2.9 Deployment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Solutions
      • 5.6.3.9 Deployment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Solutions
      • 5.6.4.9 Deployment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Solutions
      • 5.6.5.9 Deployment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 bioMerieux
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Luminex Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Alere Inc
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 OpGen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Accelerate Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Meridian Bioscience
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 T2 Biosystems
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Mobidiag
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Becton Dickinson
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Roche Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Siemens Healthineers
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bruker Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Qiagen
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Abbott Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us